Friday, April 08, 2022 5:18:15 PM
SPECIFIC INTERESTS
In the titles of their published articles, experts often reveal their very specific interests.
Here is the title of the one article written by Toon Stegmann in 2012-2022 about Communicable Diseases:
New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes. 2020
Mymetics SA, 4 Route de la Corniche, 1066 Epalinges, Switzerland. · Catalent U.K. Swindon Zydis Limited, Frankland Road, Blagrove, Swindon, SN5 8RU Wiltshire UK. · Upperton Limited, Albert Einstein Centre, Nottingham Science Park, Nottingham, NG7 2TN UK. · Chimera Biotec GmbH, Emil-Figge-Strasse 76A, 44227 Dortmund, Germany. · Mymetics BV, JH Oortweg 21, 2333 CH Leiden, The Netherlands. · 6Bachem AG, Hauptstrasse 144, 4416 Bubendorf, Switzerland. · 7Centre d'immunologie et des Maladies Infectieuses, Sorbonne Université, INSERM U1135, Paris, France. · Pubmed 32435515
https://expertscape.com/au/infectious+diseases/Stegmann%2C+Toon
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM